Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer

International Journal of Oncology

Volumn 31, Issue 2, 2007, Pages 333-338

  Kosaka, Yoshimasa ^a,b   Mimori, Koshi ^a   Tanaka, Fumiaki ^a   Inoue, Hiroshi ^a   Watanabe, Masahiko ^b   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; LATS1; Liver metastasis; MATS1; Tumor suppressor

Indexed keywords

MESSENGER RNA; MOBK1B PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

AGED; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; DROSOPHILA MELANOGASTER; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ANIMALS; APOPTOSIS; COLORECTAL NEOPLASMS; DROSOPHILA MELANOGASTER; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RNA, MESSENGER;

EID: 35148863626     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.2.333     Document Type: Article

References (34)

1. Lai ZC, Wei X, Shimizu T, et al: Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685, 2005.
2. Hergovich A, Schmitz D and Hemmings BA: The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun 345: 50-58, 2006.
3. Bothos J, Tuttle RL, Ottey M, Luca FC and Halazonetis TD: Human LATS1 is a mitotic exit network kinase. Cancer Res 65: 6568-6575, 2005. (Pubitemid 41060692)
4. Hay BA and Guo M: Coupling cell growth, proliferation, and death. Hippo weighs in. Dev Cell 5: 361-363, 2003.
5. Ryoo HD and Steller H: Hippo and its mission for growth control. Nat Cell Biol 5: 853-855, 2003.
6. Rothenberg ME and Jan YN: Cell biology: the hippo hypothesis. Nature 425: 469-470, 2003.
7. Yang X, Yu K, Hao Y, et al: LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat Cell Biol 6: 609-617, 2004. (Pubitemid 38960918)
8. Tao W, Zhang S, Turenchalk GS, et al: Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 21: 177-181, 1999.
9. Xu T, Wang W, Zhang S, Stewart RA and Yu W: Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121: 1053-1063, 1995.
10. Yang X, Li DM, Chen W and Xu T: Human homologue of Drosophila lats, LATS1, negatively regulates growth by inducing G(2)/M arrest or apoptosis. Oncogene 20: 6516-6523, 2001. (Pubitemid 32980276)
11. Kuninaka S, Nomura M, Hirota T, et al: The tumor suppressor WARTS activates the Omi/HtrA2-dependent pathway of cell death. Oncogene 24: 5287-5298, 2005.
12. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA and Sillje HH: The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24: 2076-2086, 2005. (Pubitemid 40516201)
13. Hansen LL, Jensen LL, Dimitrakakis C, et al: Allelic imbalance in selected chromosomal regions in ovarian cancer. Cancer Genet Cytogenet 139: 1-8, 2002.
14. Hisaoka M, Tanaka A and Hashimoto H: Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab Invest 82: 1427-1435, 2002. (Pubitemid 35191546)
15. Takahashi Y, Miyoshi Y, Takahata C, et al: Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res 11: 1380-1385, 2005.
16. Asaka S, Fujimoto T, Akaishi J, Ogawa K and Onda M: Genetic prognostic index influences patient outcome for node-positive breast cancer. Surg Today 36: 793-801, 2006. (Pubitemid 44306193)
17. Jiang Z, Li X, Hu J, et al: Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res 56: 450-458, 2006.
18. Japanese Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 6th edition. Kanehara, Tokyo, 1998.
19. Nishida K, Mine S, Utsunomiya T, et al: Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. Cancer Res 65: 401-409, 2005.
20. Utsunomiya T, Okamoto M, Hashimoto M, et al: A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. J Hepatol 41: 399-406, 2004.
21. Utsunomiya T, Hara Y, Kataoka A, et al: Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival. Clin Cancer Res 8: 2591-2594, 2002.
22. Utsunomiya T, Inoue H, Taguchi K, Shimada M, Sugimachi K and Mori M: G protein gamma 7 expression as a new clinicopathological marker in patients with intrahepatic cholangiocarcinoma. Arch Surg 137: 181-185, 2002. (Pubitemid 34142135)
23. Masuda TA, Inoue H, Nishida K, et al: Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res 9: 5693-5698, 2003.
24. Ogawa K, Utsunomiya T, Mimori K, et al: Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma. Br J Cancer 91: 282-286, 2004.
25. Minsky B and Mies C: The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum 32: 794-803, 1989. (Pubitemid 19215933)
26. Minsky BD, Mies C, Recht A, Rich TA and Chaffey JT: Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer 61: 1417-1424, 1988.
27. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S and Ben Ari G: Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 61: 1018-1023, 1988.
28. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ and Morson BC: Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg 141: 15-17, 1981. (Pubitemid 11170367)
29. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ and Morson BC: Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 5: 141-163, 1981. (Pubitemid 11039331)
30. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ and Morson BC: The clinical significance of invasion of veins by rectal cancer. Br J Surg 67: 439-442, 1980. (Pubitemid 10059642)
31. Lui KK, Enjoji M and Inokuchi K: Venous permeation of colorectal carcinoma. Jpn J Surg 10: 284-289, 1980.
32. Taylor I: Liver metastases from colorectal cancer: lessons from past and present clinical studies. Br J Surg 83: 456-460, 1996.
33. Scheele J, Stangl R and Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241-1246, 1990.
34. Doci R, Gennari L, Bignami P, Montalto F, Morabito A and Bozzetti F: One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78: 797-801, 1991.